Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy
Peptinovo Biopharma in Collaboration with Chemelectiva Announces Breakthrough Manufacturing Innovation for Targeted Chemotherapy First-of-its-kind semi-synthetic vitamin E product enables scalable, FDA-compliant production of Peptinovo's proprietary cancer prodrugs GlobeNewswire December 17, 2025 ANN ARBOR, Mich., Dec. 17, 2025 (GLOBE NEWSWIRE) — Peptinovo Biopharma, an Ann Arbor-based biotechnology company pioneering targeted cancer therapies through its proprietary PALM(TM) […]